TRANSBIOMED
Transbiomed is a Barcelona, Spain-based biotechnolgy company. The company, has developed a urine test that allows early diagnosis of prostate cancer and intends to use the funding to begin clinical validation of its innovations in different Spanish hospitals. Transbiomed aims to propose the device as an alternative to biopsy to determine the existence of this type of cancer. The target is to start commercializing the device by 2013.
TRANSBIOMED
Social Links:
Industry:
Biotechnology Clinical Trials Health Diagnostics Medical
Founded:
2007-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.transbiomed.net
Total Employee:
1+
Status:
Closed
Total Funding:
1.2 M EUR
Similar Organizations
BioXpedia
BioXpedia is a contract research laboratory focusing on delivering high quality cost effective Targeted Biomarker Screening to pre-clinical.
EntomoPharm
EntomoPharm, a biotechnology company, develops insect based screening models for predicting ADMET properties of chemical agents.
Henogen
Henogen is a biotechnology company addressing biomanufacturing issues under the general umbrella "from gene to the clinical product.
MTM Laboratories
MTM Laboratories manufactures in-vitro diagnostics for the early-detection and diagnosis of cervical and other cancers.
Proteo Biotech
Proteo Biotech expertise in clinical technology with the discovery and development of medical treatment for the prevention of diseases.
Current Employees Featured
Founder
Investors List
Inveready
Inveready investment in Venture Round - Transbiomed
Ministry of Business, Innovation and Employment
Ministry of Business, Innovation and Employment investment in Venture Round - Transbiomed
More informations about "Transbiomed"
Transbiomed - Crunchbase Company Profile & Funding
Transbiomed is a Barcelona, Spain-based biotechnolgy company. The company, has developed a urine test that allows early diagnosis of prostate cancer and intends to use the funding to begin clinical validation of its innovations in …See details»
Transbiomed Company Profile 2024: Valuation, Investors
Transbiomed General Information Description. Developer of non-invasive molecular diagnostic therapies. The company is focused on biomarker discovery and development through to …See details»
Transbiomed - Products, Competitors, Financials, Employees ...
Feb 10, 2013 Transbiomed is a Spanish biotech company aimed at developing new in vitro molecular diagnostics based on genomic and proteomic technologies to target large markets …See details»
Transbiomed - VentureRadar
" TRANSBIOMED, the first spin-off of the Vall d'Hebron Institute for Research (VHIR) in Barcelona, was founded in December 2007 by Dr. Jaume Reventós, Andreas Doll and Miguel …See details»
Transbiomed - Crunchbase
Transbiomed is a Spain-based biotechnology company developing a urine test for the early detection and diagnosis of prostate cancer. Search Crunchbase. Start Free Trial . Chrome …See details»
Transbiomed - Funding, Financials, Valuation & Investors
Transbiomed is a Spain-based biotechnology company developing a urine test for the early detection and diagnosis of prostate cancer. Search Crunchbase. ... How much funding has this …See details»
Transbiomed Asset Profile | Preqin
Founded in 2007, Transbiomed is a Barcelona, Spain-based biotechnology company. It developed a urine test that allows early diagnosis of prostate cancer and intends to use the …See details»
Transbiomed - Raised $1.63M Funding from 2 investors - Tracxn
Oct 22, 2024 Transbiomed has raised a total funding of $1.63M over 1 round from 2 investors. Investor includes Inveready. Their latest funding round was of $1.63M on Feb 19, 2011 .See details»
Transbiomed - Company Profile - Tracxn
Nov 15, 2024 Transbiomed ranks 221st among 629 active competitors. 170 of its competitors are funded while 118 have exited. Overall, Transbiomed and its competitors have raised over $10.8B in funding across 662 funding rounds …See details»
Inveready takes a stake in Transbiomed, the first spin-off of VHIR
Inveready Seed Capital, Venture Capital led and participated by Inveready Group, has announced its investment in the company Transbiomed in its first round of funding. Inveready has taken a …See details»
Amadix acquires Transbiomed - 2013-02-10 - Crunchbase
Feb 10, 2013 Transbiomed Transbiomed is a Spain-based biotechnology company developing a urine test for the early detection and diagnosis of prostate cancer. Acquiring Organization: …See details»
Andreas Doll – Founding partner, R&D&i – Transbiomed | LinkedIn
Investigator Miguel Servet en VALL D'HEBRON INSTITUT DE RECERCA · My scientific career and my work is focused on the molecular, translational and clinical aspects of prostate …See details»
Transbiomed - CB Insights
Feb 10, 2013 transbiomed.net. Overview & Products; Financials; ... Funding, Valuation & Revenue. 1 Fundings. Transbiomed's latest funding round was a Merger for on February 10, …See details»
Transbiomed CEO, Founder, Key Executive Team, Board of …
Explore {Transbiomed's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Transbiomed - VentureRadar
TRANSBIOMED, the first spin-off of the Vall d'Hebron Institute for Research (VHIR) in Barcelona, was founded in December 2007 by Dr. Jaume Reventós, Andreas Doll and Miguel Abal …See details»
Transbiomed - Contacts, Employees, Board Members, Advisors
Organization. Transbiomed . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Transbiomed has 2 current …See details»
The word from the Director - BaRITOn - Bordeaux Research in ...
At the INSERM research Unit side, our laboratory provides all facilities for molecular biology including quantitative PCR, cell culture, cell biology including a fully automated cell tracking …See details»
NEWS - transbiomedsolutions
TransBioMed solutions is happy to have contributed to the design and scientific organization of the first SMA-EUROPE workshop on "Mapping out opportunities and challenges for SMA …See details»
Julia Winter, new CEO of Transbiomed, VHIR’s spin-off
Julia Winter is the new CEO of Transbiomed, the spin-off of the Vall d'Hebron, Institut de Recerca (VHIR) that has recently developed a urine test for early diagnosis of prostate cancer. Born in …See details»
Mark Cuban On How He Transformed The Dallas Mavericks Into A ...
12 hours ago Mark Cuban’s transformation of the Dallas Mavericks into a championship organization stands as one of the most compelling stories in modern sports ownership. When …See details»